These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 16448887)

  • 1. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects.
    Zakopoulos NA; Ikonomidis I; Vemmos KN; Manios E; Spiliopoulou I; Tsivgoulis G; Spengos K; Psaltopoulou D; Mavrikakis M; Moulopoulos SD
    Am J Hypertens; 2006 Feb; 19(2):170-7. PubMed ID: 16448887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Gattobigio R; Ambrosio G; Porcellati C
    Eur Heart J; 2002 Apr; 23(8):658-65. PubMed ID: 11969281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular structure and function in previously untreated hypertensive patients: the importance of blood pressure, the nocturnal blood pressure dip and heart rate.
    Mayet J; Shahi M; Hughes AD; Stanton AV; Poulter NR; Sever PS; Foale RA; Thom SA
    J Cardiovasc Risk; 1995 Jun; 2(3):255-61. PubMed ID: 7584802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
    Eguchi K; Kario K; Hoshide S; Ishikawa J; Morinari M; Shimada K
    Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension.
    Tsioufis C; Stougiannos P; Kakkavas A; Toutouza M; Mariolis A; Vlasseros I; Stefanadis C; Kallikazaros I
    Am J Cardiol; 2005 Jul; 96(2):252-6. PubMed ID: 16018852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular geometry, ambulatory blood pressure and extra-cardiac organ damage in untreated essential hypertension.
    Cuspidi C; Giudici V; Negri F; Sala C; Mancia G
    Blood Press Monit; 2010 Jun; 15(3):124-31. PubMed ID: 20305545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimate of white-coat effect and arterial stiffness.
    de Simone G; Schillaci G; Chinali M; Angeli F; Reboldi GP; Verdecchia P
    J Hypertens; 2007 Apr; 25(4):827-31. PubMed ID: 17351375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
    Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in left ventricular function in patients with isolated aortic stenosis.
    Favero L; Giordan M; Tarantini G; Ramondo AB; Cardaioli P; Isabella G; Chioin R; Lupia M; Razzolini R
    J Heart Valve Dis; 2003 May; 12(3):313-8. PubMed ID: 12803330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-hour mean heart rate and likelihood of left ventricular hypertrophy.
    Palmieri V
    Am J Hypertens; 2006 Feb; 19(2):178. PubMed ID: 16448888
    [No Abstract]   [Full Text] [Related]  

  • 14. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
    Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
    Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory intraarterial blood pressure in essential hypertension. Effects of age, sex, race, and body mass--the Northwick Park Hospital Database Study.
    Acharya DU; Heber ME; Doré CJ; Raftery EB
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):943-52. PubMed ID: 8896645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients.
    Matsui Y; Eguchi K; Shibasaki S; Shimizu M; Ishikawa J; Shimada K; Kario K
    J Hypertens; 2009 Apr; 27(4):712-20. PubMed ID: 19516171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B; Fabbian F; Giles M; Johnston A; Baker LR
    Clin Nephrol; 1999 Dec; 52(6):377-82. PubMed ID: 10604646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension.
    van Boxtel MP; Henskens LH; Kroon AA; Hofman PA; Gronenschild EH; Jolles J; de Leeuw PW
    J Hum Hypertens; 2006 Jan; 20(1):5-13. PubMed ID: 16163365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulse blood pressure (according to 24-hour monitoring) and left ventricular myocardial structural changes in patients with hypertensive disease].
    Oshchepkova EV; Zelveian PA; Buniatian MS; Rogoza AN; Sergakova LM
    Ter Arkh; 2002; 74(12):21-4. PubMed ID: 12577833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.